Publisher
Springer Berlin Heidelberg
Reference159 articles.
1. Abraham E, Wunderink R, Silverman H, Perl TM, Nasraway S, Levy H, Bone R, Wenzel RP, Balk R, Allred R, Pennington JE, Wherry JC (1995) Efficacy and safety of monoclonal antibody to human tumor necrosis factor-α in patients with sepsis syndrome. JAMA 273: 934–941.
2. Aderka D, Le JM, Vilcek J (1989) IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J Immunol 143: 3517–3523.
3. Aderka D, Engelmann H, Hornik V, Skorick Y, Levo Y, Wallach D, Kushtai G (1991) Increased serum levels of soluble receptors for tumor necrosis in cancer patients. Cancer Res 51: 5602–5607.
4. Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D (1992) stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 175: 323–329.
5. Aiura K, Gelfand JA, Wakabayashi G, Burke JF, Thompson RC, Dinarello CA (1993) lnterleukin-1 (IL-1) receptor antagonist prevents Staphylococcus epidermidis-induced hypotension and reduces circulating levels of tumor necrosis factor and IL-1β in rabbits. Infect Immun 61: 3342–3350.
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献